We are live on ! Find out more
WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+19.54%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$1.26B
AUM Growth
+$431M
Cap. Flow
+$257M
Cap. Flow %
20.49%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
6
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
AUTL
Autolus Therapeutics
AUTL
+$249M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$74.6M
3
TBPH icon
Theravance Biopharma
TBPH
+$13.1M
4
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$7.56M
5
BIIB icon
Biogen
BIIB
+$5.16M

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$89.3M
2
MO icon
Altria Group
MO
+$6.7M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBPH icon
1
Theravance Biopharma
TBPH
$877M
$382M 30.43%
11,694,879
+481,000
+4% +$13.1M
AUTL
2
Autolus Therapeutics
AUTL
$562M
$332M 26.44%
10,825,919
+9,234,176
+580% +$249M
PRTA icon
3
Prothena Corp
PRTA
$450M
$156M 12.42%
11,924,614
– –
ALKS icon
4
Alkermes
ALKS
$8.25B
$113M 8.99%
2,659,676
-2,057,334
-44% -$89.3M
BIIB icon
5
Biogen
BIIB
$30.7B
$104M 8.29%
294,564
+15,000
+5% +$5.16M
AGIO icon
6
Agios Pharmaceuticals
AGIO
$1.93B
$102M 8.09%
1,317,459
+927,459
+238% +$74.6M
EVFM
7
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$38.9M 3.09%
639,546
– –
NCNA
8
NuCana
NCNA
$6.12M
$14.3M 1.14%
114
+30
+36% +$3.54M
NITE
9
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$13.9M 1.11%
682,109
+368,109
+117% +$7.56M
MO icon
10
Altria Group
MO
$114B
– –
-118,000
Closed -$6.7M

Similar funds

LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 2.79% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return

Woodford Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Woodford Investment Management held 10 positions worth $1.26B, up 52% from $825M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Woodford Investment Management deployed $257M of net new capital in Q3 2018, adding to 6 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was Alkermes, an estimated $89.3M trimmed.

  • Woodford Investment Management added most to Autolus Therapeutics in Q3 2018, an estimated $249M increase.
  • Woodford Investment Management's biggest Q3 2018 reduction was Alkermes, cutting an estimated $89.3M.
  • Woodford Investment Management fully exited Altria Group in Q3 2018, selling an estimated $6.7M.
  • Woodford Investment Management's ten largest holdings make up 100% of its $1.26B portfolio in Q3 2018.
  • Woodford Investment Management opened 0 new positions and closed 1 in Q3 2018.
  • Woodford Investment Management's portfolio value rose 52% quarter-over-quarter to $1.26B.

Based on Woodford Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.